Antonio Cittadini

Centro Tecnológico de la Carne de Galicia, Avd. Galicia No. 4, Parque Tecnológico de Galicia, San Cibrao das Viñas, 32900 Ourense, Spain.

50 publications 2023 – 2026 ORCID

What does Antonio Cittadini research?

Antonio Cittadini studies the effects of various medical conditions on heart health, particularly in patients with myasthenia gravis, post-COVID-19 syndrome, and hypertension. His research examines how these conditions can impact the heart, leading to complications like atrioventricular block or diastolic dysfunction. He also explores potential treatments, including combinations of supplements, to enhance recovery and exercise capacity in affected individuals.

Key findings

  • In a case study of a 62-year-old man with myasthenia gravis, it was found that timely diagnosis of atrioventricular block significantly improved his quality of life after receiving a pacemaker.
  • Patients recovering from COVID-19 who took a combination of supplements improved their walking distance by an average of 40 meters in six minutes, compared to just 10 meters for those who did not take the supplements.
  • In a study on hypertension, 2% of healthy individuals showed signs of diastolic dysfunction, with the rate rising to 8% in patients with a thickened heart wall.

Frequently asked questions

Does Dr. Cittadini study heart problems related to myasthenia gravis?
Yes, he focuses on how myasthenia gravis can lead to heart issues such as atrioventricular block.
What treatments has Dr. Cittadini researched for post-COVID recovery?
He has researched the beneficial effects of a combination of supplements, which significantly improved exercise capacity in patients recovering from COVID-19.
Is Dr. Cittadini's work relevant to patients with high blood pressure?
Yes, his research helps identify heart function problems in patients with high blood pressure, which can occur even without visible symptoms.

Publications in plain English

Predicting exercise pulmonary hypertension: the right-net machine learning model a pilot study.

2026

Translational research : the journal of laboratory and clinical medicine

Ferrara F, Castaldo R, Gargani L, Benjamin N, Carbone A +21 more

Plain English
This study explored a new machine learning model to predict abnormal blood pressure responses in the lungs during exercise, using routine health measurements. Researchers analyzed data from 417 individuals (221 healthy adults and 196 with connective tissue disease) and found that the model was very effective, with an accuracy score of 0.92 in identifying those at risk for exercise-related pulmonary hypertension. This is important because early detection can help manage potential heart and lung complications linked to hypertension during physical activity. Who this helps: Patients at risk of pulmonary hypertension, especially those with underlying health conditions.

PubMed

To dilate or not to dilate: the puzzle of phenotyping heart failure with mildly reduced ejection fraction.

2026

European journal of internal medicine

Esposito G, Marra AM, Cittadini A

PubMed

Gut and Heart Axis Affects Cardiometabolic Health Through the Ages. A Special Focus on Adolescence.

2026

Journal of the Endocrine Society

Salzano A, Cittadini A

PubMed

Cardiopulmonary exercise test criteria for heart transplantation referral of patients with ambulatory heart failure in the current era.

2026

Heart (British Cardiac Society)

Azar M, Apostolo A, Salvioni E, Galotta A, Emdin M +41 more

Plain English
This study looked at heart failure patients who can still walk but may need a heart transplant. Researchers analyzed data from over 8,000 patients, focusing on 1,218 with severe heart problems and low peak oxygen levels. They found that some patients with low peak oxygen levels actually lived longer than those who received heart transplants, especially if they had better exercise efficiency and no specific breathing issues during exercise. This finding suggests that the current guidelines for deciding who should be considered for a heart transplant need to be updated. Who this helps: Patients with heart failure and their doctors.

PubMed

Patterns and Clinical Outcomes of Sitagliptin/Metformin Extended-Release in Internal Medicine: A Real-World Multicenter Italian Study.

2026

Journal of clinical medicine

De Luca M, Arcopinto M, Bosco G, Cicco S, Di Giacomo Barbagallo F +10 more

Plain English
This study looked at how a combination medication called sitagliptin and extended-release metformin (SITA/MET ER) affects patients with type 2 diabetes, especially those who have other health issues. Researchers found that among 292 patients, average blood sugar levels improved from 7.4% to 7.0% after a few months, and patients generally followed their treatment well, with no side effects reported. This matters because it shows that SITA/MET ER can help manage diabetes effectively in older patients who may have multiple health problems. Who this helps: Patients with type 2 diabetes, especially older adults with other health issues.

PubMed

MECKI score thresholds for heart transplantation referral of ambulatory heart failure patients.

2026

ESC heart failure

Agostoni P, Galotta A, Salvioni E, Mapelli M, Emdin M +40 more

Plain English
This study looked at a scoring system called the MECKI score to help determine which heart failure patients might need a heart transplant. Researchers found that patients with a MECKI score of 0.1368 or higher had worse survival rates than those who received transplants, with a 5-year survival rate of 83.7% for the overall group compared to 71.2% for transplant recipients. Establishing this score helps identify patients who should be considered for transplants, improving their chances for better outcomes. Who this helps: This helps patients with heart failure and their doctors by providing clearer guidelines for when to consider heart transplantation.

PubMed

Sex-Related Differences in Clinical Profile, Management, and Outcomes of Patients With Type A and B Acute Aortic Dissection: Observations From IRAD.

2026

Journal of the American Heart Association

Jackson E, Carbone A, Shalhub S, Pai CW, Ehrlich M +10 more

Plain English
This study investigated how men and women differ in their experiences with acute aortic dissection, a serious condition that affects the large blood vessel from the heart. It analyzed data from over 11,500 patients and found that women were older and often received diagnoses later than men. Additionally, women were less likely to undergo surgery for type A aortic dissection, resulting in higher in-hospital death rates and lower long-term survival—81.4% for women compared to 86.6% for men after four years. Who this helps: This helps doctors and healthcare providers better understand the treatment needs of women with aortic dissection.

PubMed

Integrating Host Genetics and Clinical Setting in Machine Learning Models: Predicting COVID-19 Prognosis for Healthcare Decision-Making (The FeMiNa Study).

2026

Diagnostics (Basel, Switzerland)

D'Aversa E, Antonica B, Grisafi M, Asselta R, Paraboschi EM +12 more

Plain English
This study looked at ways to predict which COVID-19 patients are at the highest risk of dying by combining their genetic information with clinical data. Researchers analyzed 532 hospitalized patients and found that their machine learning model performed well, accurately identifying high-risk patients and reducing false alarms. They discovered that age was the strongest predictor of mortality, along with the need for ventilation, showing that both genetic and clinical factors are important in making these predictions. Who this helps: This benefits doctors and healthcare providers by improving their ability to prioritize care for the most vulnerable patients.

PubMed

Prognostic Thresholds of Pulmonary Artery Pressure and Right Ventricular Function at Echocardiography in Heart Failure.

2026

The American journal of cardiology

Ghio S, Carluccio E, Franzese M, Acquaro M, Biagioli P +14 more

Plain English
This study looked at how measurements from echocardiograms, specifically the TAPSE (a measure of heart function) and pulmonary artery pressure (sPAP), can help predict the risk of death in heart failure patients. Researchers found that higher pulmonary artery pressure and lower TAPSE were linked to a greater risk of mortality, with specific concerning values being 33 mmHg for sPAP, 19 mm for TAPSE, and a ratio of 0.68 for TAPSE/sPAP. This information is important because it helps doctors identify which heart failure patients are at higher risk for severe outcomes, so they can provide better care. Who this helps: This helps patients with heart failure and their doctors.

PubMed

Cardiac rehabilitation in overweight and obese patients: Challenges, strategies, and the role of emerging anti-obesity therapies.

2026

Current problems in cardiology

De Luca M, Modestino MR, Alsergani A, Gabriele M, Galzerano D +4 more

Plain English
This study looked at how cardiac rehabilitation (CR) helps overweight and obese patients with heart issues. The researchers found that participating in CR improved patients' fitness, cardiovascular health, and quality of life, even if their weight loss was modest, with improvements in fitness being the most important for better health outcomes. Understanding the challenges these patients face and incorporating personalized treatments, including new medications for weight loss, can help make CR more effective. Who this helps: This helps patients with obesity and heart disease, as well as doctors who support their recovery.

PubMed

Influence of Agro-Industrial By-Products Inclusion on Growth Parameters and Carcass Quality inLambs.

2026

Animals : an open access journal from MDPI

Cittadini A, Bermúdez R, Cadavez V, González-Peaguda A, Bodas R +1 more

Plain English
This study looked at how adding 10% of ingredients like dried brewers' grain, grape pomace, or olive cake to the diets of 32 lambs affected their growth and meat quality. The researchers found no significant differences in weight gain, fat levels, or meat quality among the different diets, meaning all the lambs grew similarly regardless of what was in their food. This matters because it shows that using these agricultural by-products as animal feed can be a sustainable option without harming the quality of the meat. Who this helps: Farmers and producers raising lambs.

PubMed

Reduction of inappropriate shock rate through signal filtering (smart-pass) in patients with implantable subcutaneous cardioverter-defibrillator: a systematic review and meta-analysis.

2025

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

Santomauro M, Petretta M, Riganti C, Santomauro MA, De Luca M +2 more

Plain English
The study looked at how using a special filter (called SMART-pass) affects the rate of inappropriate shocks in patients with subcutaneous implantable cardioverter-defibrillators (S-ICDs). Researchers analyzed data from 6,111 patients and found that those with the filter experienced significantly fewer inappropriate shocks—3.61% compared to 10.75% for those without the filter. This is important because it means that the new technology can help reduce unnecessary shocks, leading to better patient outcomes and comfort. Who this helps: This benefits patients with implantable defibrillators, as well as their doctors.

PubMed

Lipid-lowering therapy in patients with coronary heart disease: an Italian real-life survey. Results from the Survey on Risk FactOrs and CardiovascuLar secondary prEvention and drug strategieS (SOFOCLES) in Italy.

2025

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

Aragona CO, Bianco A, Caruso R, Cerulli M, Cosentino N +7 more

Plain English
This study looked at how well patients in Italy with coronary heart disease manage their cholesterol levels with lipid-lowering medications. Out of 2,532 patients, only 58% reached the recommended cholesterol level of under 70 mg/dL, and just 27% reached the more stringent target of under 55 mg/dL. The findings show that many patients are not receiving adequate treatment and highlight the need for better healthcare strategies, especially for those with lower education levels. Who this helps: This benefits patients with coronary heart disease and healthcare providers working on better treatment strategies.

PubMed

The chronic heart failure evolutions: Different fates and routes.

2025

ESC heart failure

Agostoni P, Chiesa M, Salvioni E, Emdin M, Piepoli M +45 more

Plain English
This study looked at over 4,800 patients with chronic heart failure to understand how their conditions progress over time. They found that patients could be grouped into 19 different types based on their symptoms and health evaluations, with survival rates varying significantly—ranging from 44% to 100% after two years, and from 20% to 100% after five years. Understanding these different patterns helps doctors better predict outcomes and customize treatment plans for heart failure patients. Who this helps: This helps patients with chronic heart failure by enabling more personalized treatment and better management of their condition.

PubMed

The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit: Diagnostic and Prognostic Implications.

2025

Heart failure clinics

Giardino F, Douschan P, Paolillo S, Basile C, Cademartiri F +3 more

Plain English
This study looked at different non-invasive methods to assess how well the lungs and right side of the heart are working together. It found that various techniques, like ultrasound and MRI, can help identify early changes in this part of the cardiovascular system, which is important for timely treatment and understanding patient outcomes. Knowing how well these areas function is crucial because it helps doctors make better decisions about care for patients with heart and lung issues. Who this helps: This helps patients with heart and lung problems, as well as their doctors.

PubMed

Sex-Specific Differences in Echocardiographic Parameters of Risk Stratification in Pulmonary Arterial Hypertension.

2025

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

Benjamin N, Schiffer V, Resag C, Xanthouli P, Braun M +8 more

Plain English
This study looked at how the size of the right side of the heart differs between men and women with pulmonary arterial hypertension (PAH) and how those differences affect survival predictions. Researchers found that men had larger heart areas—21.76 cm for the right atrium and 24.02 cm for the right ventricle—compared to women, whose sizes were 17.65 cm and 18.41 cm respectively. It's important because understanding these sex differences can help doctors better predict outcomes and tailor treatments for PAH patients. Who this helps: Patients with pulmonary arterial hypertension and their doctors.

PubMed

Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction: A Randomized, Double-Blind, Placebo-Controlled Trial.

2025

JACC. Heart failure

Marra AM, D'Assante R, De Luca M, Arcopinto M, Gargiulo P +16 more

Plain English
This study looked at how growth hormone replacement therapy affects patients with heart failure and low growth hormone levels. Researchers found that after one year, patients receiving growth hormone showed a significant improvement in their exercise capacity (increased from 12.8 to 15.5 mL/kg/min) and quality of life, with better heart function and reduced hospitalizations. This matters because it shows that growth hormone therapy can significantly enhance the health and daily lives of heart failure patients. Who this helps: Patients with heart failure and low growth hormone levels.

PubMed

Exercise Echocardiography of Left Ventricular Diastolic Function in Healthy Subjects: Insights From the RIGHT-NET.

2025

CJC open

Ferrara F, Carbone A, Gargani L, Castaldo R, Argiento P +23 more

Plain English
This study looked at how heart function changes during exercise in 192 healthy adults, specifically focusing on the left side of the heart (the left ventricle). Researchers found that a key measurement called the E/e' ratio increased from an average of 6.3 to 7.3 during moderate exercise, showing that even healthy hearts respond to exercise intensity. Understanding these changes helps doctors better assess heart health and function under different conditions. Who this helps: This helps doctors and cardiologists in evaluating heart function in patients.

PubMed

Post-implantation syndrome in patients undergoing thoracic and abdominal endovascular aortic repair: Comprehensive systematic review and meta-analysis.

2025

Current problems in cardiology

Carbone A, Turchino D, Fanti C, Bottino R, Ferrara F +9 more

Plain English
This research focused on post-implantation syndrome (PIS) in patients who underwent a specific type of surgery to repair damaged blood vessels in the chest and abdomen. Out of nearly 2,900 patients studied, about 882 (30.5%) developed PIS, which often included symptoms like fever. Those with PIS tended to stay in the hospital longer and, although the overall outcomes were largely the same, two studies indicated a higher risk of serious heart-related events in these patients. Who this helps: This research benefits doctors and healthcare teams managing patients undergoing aortic repair surgeries.

PubMed

The Role of Aging in Heart Failure With Preserved Ejection Fraction: Focus on Proteostatic Imbalance.

2025

JACC. Basic to translational science

Salzano A, Cittadini A

PubMed

Cardio-Oncology Challenges in Elderly Patients.

2025

Journal of clinical medicine

Topa E, De Rosa E, Cuomo A, Curcio F, Rizza M +25 more

Plain English
This study looked at elderly cancer patients and how heart disease affects their treatment and survival. Researchers analyzed 108 patients, finding that those currently undergoing cancer treatment faced the highest rates of heart-related events (61.8%) compared to those not treated (14.8%) or who had completed treatment (15%). Notably, the survival rate after four years was also lower for those currently in treatment at 47.1%, compared to 22.2% for those starting treatment and 20% for those who had finished. Who this helps: This benefits elderly cancer patients and their doctors by identifying those at higher risk for heart issues during treatment.

PubMed

Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with Hormonal Deficiencies.

2025

International journal of molecular sciences

Grimaldi AM, D'Assante R, Fiore F, Marcella S, Paolillo S +6 more

Plain English
This study looked at specific tiny molecules called miRNAs in people with heart failure (HF) to see how they relate to hormonal deficiencies. Researchers found that three miRNAs—miR-10b-5p, miR-193a-3p, and miR-1-3p—were found in lower amounts in heart failure patients compared to healthy individuals, particularly those with less severe heart failure. Notably, miR-10b-5p was especially good at identifying patients with both heart failure and hormonal deficiencies, with an accuracy score of 80%. Who this helps: This helps patients with heart failure and hormonal issues, as well as their doctors in diagnosing and managing their condition.

PubMed

Exercise Doppler Echocardiography of the Right Heart and Pulmonary Circulation in Patients With Cardiovascular Risk Factors: Observations From the RIGHT Heart International NETwork (RIGHT-NET).

2025

Chest

De Luca M, Ferrara F, Gargani L, Argiento P, Bandera F +22 more

Plain English
This study looked at how cardiovascular risk factors (like high blood pressure or diabetes) impact the right side of the heart and blood circulation in patients who don't have overt heart disease. Researchers compared 362 patients with at least one risk factor to 375 healthy individuals and found that patients with more than two risk factors had worse heart function and exercise capacity, with 12 hospital events compared to just one in healthy controls. This matters because it highlights that even individuals without diagnosed heart disease can still face significant risks and limitations due to these factors. Who this helps: This helps patients with cardiovascular risk factors and their doctors in managing heart health.

PubMed

Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: the MECKI-RENAL study.

2025

European heart journal. Quality of care & clinical outcomes

Mapelli M, Salvioni E, Cosentino N, Pluchinotta F, Galotta A +50 more

Plain English
This study looked at how different formulas for estimating kidney function affect the accuracy of predicting outcomes in patients with heart failure. Researchers analyzed data from 6,933 patients and found that the six formulas provided similar levels of accuracy for predicting survival, with survival prediction ranging from about 63% to 64% accuracy. This matters because understanding kidney function is crucial for managing heart failure effectively, and the MECKI score remains a reliable tool for assessing patient risk, regardless of which estimation formula is used. Who this helps: This helps heart failure patients and their doctors.

PubMed

Non cardiovascular comorbidities in Heart Failure. An updated position paper from the Heart Failure Working Group of the Italian Society of Cardiology (SIC).

2025

European journal of internal medicine

Correale M, Salzano A, Tricarico L, Cittadini A, Crisci G +15 more

Plain English
This research paper examines how other diseases not related to the heart (called non-cardiovascular comorbidities) affect people with Heart Failure (HF). It finds that having multiple health issues significantly worsens HF outcomes, leading to a lower quality of life, more hospital visits, and a higher risk of death. Understanding these additional conditions is crucial because they can interfere with heart treatment and affect how quickly patients deteriorate. Who this helps: This helps patients with heart failure by highlighting the importance of managing other health issues alongside their heart disease.

PubMed

Atrioventricular block and myastenia gravis. A case report and review of the literature.

2025

Journal of basic and clinical physiology and pharmacology

Lombardi A, Murru F, Atripaldi LG, D'Argenzio C, Verdoliva R +9 more

Plain English
This study looked at a 62-year-old man with a condition called myasthenia gravis (MG), which can affect muscles and, in some cases, the heart. He developed a serious heart issue called atrioventricular block, leading to the need for a pacemaker. The findings stress the importance of monitoring heart health in MG patients, as timely diagnosis and treatment can significantly improve their quality of life. Who this helps: Patients with myasthenia gravis and their doctors.

PubMed

Exploring the physiologic variations and related determinants of left ventricular diastolic function among 381 healthy Caucasian adults by the 2016 American Society of Echocardiography-European Association of Cardiovascular Imaging guidelines.

2024

European journal of preventive cardiology

Losi MA, Bossone E, Piccolo R, Canciello G, Pacella D +6 more

PubMed

Corrigendum to "How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion" [International Journal of Cardiology 2023 381C 101-104].

2024

International journal of cardiology

Volpe M, Borghi C, Cameli M, Cianflone D, Cittadini A +5 more

PubMed

Chronic heart failure: An appropriate clinical context to search for GH deficiency?

2024

European journal of internal medicine

Cittadini A, De Luca M, Saccà L

PubMed

Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection.

2024

Journal of translational medicine

Quarto G, Benassai G, Colao A, Cittadini A, Ascierto PA +10 more

Plain English
This study looked at patients who had recovered from COVID-19 to see if thicker vein walls were related to how severely their lungs were affected by the virus. It found that patients with vein wall thickness greater than 1 mm had a higher average lung damage score of 7.4, compared to 3.82 for those with thinner walls, implying a connection between vein health and lung severity. Understanding this relationship can help improve treatment strategies for COVID-19. Who this helps: This helps patients recovering from COVID-19 and their doctors.

PubMed

Cardiac rehabilitation and acute aortic dissection: understanding and addressing the evidence GAP a systematic review.

2024

Current problems in cardiology

Carbone A, Lamberti N, Manfredini R, Trimarchi S, Palladino R +10 more

Plain English
This study looked at how cardiac rehabilitation (CR) affects patients who have experienced an acute aortic dissection (AAD), which is a serious heart condition. The review included 311 patients from five studies and found that rehabilitation generally led to better exercise ability and improved quality of life, with no negative side effects reported. The researchers highlighted the need for better research to establish safe practices for implementing CR, including training intensity and the timing of starting rehabilitation after surgery. Who this helps: This helps patients recovering from acute aortic dissection and their healthcare providers.

PubMed

Health-related quality of life in patients with aortic dissection: An unmet need.

2024

Current problems in cardiology

Carbone A, Palladino R, Franzese M, Castaldo R, Ranieri B +7 more

Plain English
This study looked at the quality of life for patients who experienced two types of aortic dissection: Type A and Type B. While most patients reported a quality of life similar to the general population, those over 80 showed better emotional health, but younger patients had lower scores in physical and mental well-being. Exercise-based cardiac rehabilitation helped improve quality of life overall. Who this helps: This research benefits patients recovering from aortic dissection and healthcare providers involved in their rehabilitation.

PubMed

Acute heart failure - an EFIM guideline critical appraisal and adaptation for internists.

2024

European journal of internal medicine

Kokorin VA, González-Franco A, Cittadini A, Kalejs O, Larina VN +6 more

Plain English
This research focuses on improving how doctors manage patients with acute heart failure (AHF) by updating guidelines that help with diagnosis and treatment. The study identified 51 specific recommendations to address complex situations with AHF, emphasizing the importance of tests like echocardiography and natriuretic peptides, and suggesting various treatment options such as intravenous support and mechanical help. This matters because it equips doctors with better strategies to treat patients and potentially lower their chances of returning to the hospital after discharge. Who this helps: This helps internists and other doctors treating patients with acute heart failure.

PubMed

Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry.

2024

Internal and emergency medicine

De Luca M, D'Assante R, Iacoviello M, Triggiani V, Rengo G +20 more

Plain English
This study looked at how subclinical hypothyroidism (SH) affects patients with heart failure over 30 months. Among 277 heart failure patients, 23 had SH, and these patients had higher thyroid-stimulating hormone (TSH) levels (averaging 7.7) compared to those without SH (averaging 1.6). Importantly, having SH was linked to nearly three times greater risk of cardiovascular death, highlighting the need for thyroid testing in heart failure patients to improve care and outcomes. Who this helps: This helps heart failure patients by identifying a risk factor that can be easily tested and managed.

PubMed

A matter of sex-persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study.

2024

Frontiers in cardiovascular medicine

Grilli G, Salvioni E, Moscucci F, Bonomi A, Sinagra G +41 more

Plain English
This study looked at how men and women with heart failure (specifically, heart failure with reduced ejection fraction) have different risks for serious outcomes like death, urgent heart transplant, or needing a heart pump. Researchers analyzed data from nearly 8,000 patients and found that men faced almost double the risk compared to women (9.7% vs. 4.1%) and that adjusting the MECKI score for sex improved its accuracy in predicting risks. This matters because it allows doctors to better assess the prognosis for heart failure patients based on their sex, leading to more personalized treatment plans. Who this helps: This helps patients with heart failure and their healthcare providers.

PubMed

Correction: Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry.

2024

Internal and emergency medicine

De Luca M, D'Assante R, Iacoviello M, Triggiani V, Rengo G +20 more

PubMed

Exercise Pulmonary Hypertension in Heart Valve Disease.

2024

Reviews in cardiovascular medicine

Schiavo A, Bellino M, Moreo A, Casadei F, Carbone A +6 more

Plain English
This study looked at exercise pulmonary hypertension (PH) in people with heart valve disease (HVD) and found that measuring PH during exercise can help predict how severely the disease will affect patients. Specifically, identifying elevated pulmonary pressure during exercise can be important for determining the right treatment approach and anticipating symptoms and survival outcomes. This matters because it could lead to better timing and choice of treatment methods for patients with HVD. Who this helps: Patients with heart valve disease and their doctors.

PubMed

Utility of cardiopulmonary exercise testing in the complexity of the long COVID syndrome. Novel findings from specific sub-groups of patients.

2024

International journal of cardiology

Salzano A, Cittadini A

PubMed

Sex and gender specific pitfalls and challenges in cardiac rehabilitation: a working hypothesis towards better inclusivity in cardiac rehabilitation programmes.

2024

European heart journal open

Marra AM, Giardino F, Salzano A, Caruso R, Parato VM +12 more

Plain English
This study looked at how sex (biological differences between men and women) and gender (social roles and identities) affect people's access to cardiac rehabilitation (CR) programs, which are crucial for preventing heart problems. It found that nearly 25% of patients who should be in CR are not getting it, with women particularly underrepresented; they often have lower referral, participation, and completion rates compared to men. This matters because addressing these obstacles can lead to better recovery for all patients, especially those who don't fit traditional gender categories. Who this helps: This research benefits patients, especially women and non-binary individuals, by promoting more inclusive cardiac rehabilitation programs.

PubMed

Aortic Dimension in Elite Athletes: Updated Systematic Review and Meta-Analysis.

2024

European journal of preventive cardiology

Carbone A, Monda E, Ferrara F, Franzese M, Bottino R +7 more

Plain English
This research looked at how the aorta, a major blood vessel, changes in size among elite athletes compared to non-athletic individuals. It was found that the aorta was about 1.69 mm larger in elite athletes and this difference remained when adjusted for height, but not when adjusted for body size. This information is important because it helps doctors understand what is normal for athletes, reducing the risk of misdiagnosis related to aortic conditions. Who this helps: This benefits athletes and their doctors.

PubMed

A pulmonary hypertension targeted algorithm to improve referral to right heart catheterization: A machine learning approach.

2024

Computational and structural biotechnology journal

Argiento P, D'Agostino A, Castaldo R, Franzese M, Mazzola M +11 more

Plain English
This study examined a method to identify patients who may have pulmonary hypertension (PH) more efficiently using machine learning. Researchers analyzed data from 226 patients and found that a specific algorithm could correctly identify those with PH 83% of the time and had an overall accuracy of 74%. This is important because it can help doctors refer patients for the necessary testing more quickly, leading to earlier diagnoses and treatment. Who this helps: This helps patients suspected of having pulmonary hypertension.

PubMed

Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study: Rationale and Design.

2024

Heart failure clinics

Marra AM, Palmiero G, Losi M, Mallardo M, Galati A +6 more

Plain English
The ERICA study is looking at how exercise training impacts patients with a specific heart condition called wild-type transthyretin cardiac amyloidosis (ATTRwt-CA). It will compare two groups of patients: one will do an exercise program while the other will not. The main measurement of success will be how far participants can walk in six minutes, along with other factors like quality of life and heart function. Who this helps: This study benefits patients with cardiac amyloidosis and their doctors by exploring the role of exercise in their treatment.

PubMed

Beneficial Effects on Exercise Capacity Associated with a Combination of Lactoferrin, Lysozyme, Lactobacillus, Resveratrol, Vitamins, and Oligoelements in Patients with Post-COVID-19 Syndrome: A Single-Center Retrospective Study.

2024

Journal of clinical medicine

Marra AM, Giardino F, Anniballo A, Ferazzoli S, Salzano A +8 more

Plain English
This study looked at whether a combination of supplements (lactoferrin, lysozyme, lactobacillus, resveratrol, vitamins, and minerals) could help improve exercise capacity in patients suffering from long-term effects after having COVID-19. The researchers found that patients who took the supplements for at least six weeks walked an average of 40 meters further in six minutes compared to their own starting point, while those who didn't take the supplements increased their distance by only 10 meters. This is important because better exercise capacity can lead to improved overall health and quality of life for post-COVID patients. Who this helps: This helps patients recovering from COVID-19.

PubMed

Application of the 2016 ASE-EACVI Criteria for the Assessment of Diastolic Function in Arterial Hypertension.

2024

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Canciello G, Izzo R, Bossone E, Piccolo R, Pacella D +11 more

Plain English
This study looked at how to assess heart function in patients with high blood pressure using two different diagnostic methods. Researchers found that diastolic dysfunction (a type of heart issue) was present in 2% of healthy individuals, 8% of those with high blood pressure who had thickened heart walls, and 7% of those without thickened walls. This is important because it highlights that high blood pressure can cause heart function problems even if patients don't show signs of thickening in their heart muscle. Who this helps: This helps doctors better identify heart issues in patients with high blood pressure.

PubMed

Heart failure patients with improved ejection fraction: Insights from the MECKI score database.

2023

European journal of heart failure

Agostoni P, Pluchinotta FR, Salvioni E, Mapelli M, Galotta A +47 more

Plain English
This study looked at heart failure patients whose heart function improved compared to those whose heart function did not improve. Researchers tracked nearly 8,000 patients and found that those with improved heart function had better health indicators, such as a higher ejection fraction (44% vs. 30%) and lower cardiovascular death rates (26.6 per 1000 person-years vs. 46.9) over time. Understanding these differences is important because it highlights that patients with improved heart function can have better outcomes, although they still face certain risks. Who this helps: Patients with heart failure and their doctors.

PubMed

Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential.

2023

Geriatrics (Basel, Switzerland)

Cataldi M, Celentano C, Bencivenga L, Arcopinto M, Resnati C +11 more

Plain English
This study looked at how certain medications can interact with each other in older patients and how genetic differences might affect these interactions. Researchers found that drugs like amiodarone, amlodipine, and atorvastatin were commonly used and could lead to issues, with specific genetic variations affecting interactions in over 2% of the European population. This knowledge is important because it can improve how doctors prescribe medications to older adults, potentially preventing harmful interactions. Who this helps: This helps older patients and their doctors make safer medication choices.

PubMed

Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201).

2023

Frontiers in neuroscience

Pane C, Marra AM, Aliberti L, Campanile M, Coscetta F +7 more

Plain English
This study examines whether dimethyl fumarate (DMF), a drug used for psoriasis and multiple sclerosis, can help improve a key protein and reduce problems with cell energy in people with Friedreich Ataxia (FRDA), a serious genetic disorder. Over 12 weeks, 60 patients will receive either DMF or a placebo, with those on DMF taking a total of 480 mg daily. Researchers specifically want to see if DMF boosts the levels of a gene and protein associated with FRDA and helps improve overall heart and lung function. Who this helps: This benefits patients with Friedreich Ataxia and their caregivers.

PubMed

Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation.

2023

Journal of the American College of Cardiology

Gargani L, Pugliese NR, De Biase N, Mazzola M, Agoston G +45 more

Plain English
This study looked at how the right side of the heart and blood flow in the lungs respond to exercise in different groups of people, including healthy individuals and those with heart or lung diseases. Researchers found that healthy people had a normal range of pressure during exercise (0.2 to 3.5 mm Hg.min/L), while those with health issues showed higher pressures and lower functioning, indicating potential problems. These findings help identify patients at risk of serious health issues, including higher death rates, based on specific measurements during exercise. Who this helps: This information benefits doctors and patients with heart or lung conditions, as it aids in assessing their health risks during exercise.

PubMed

Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.

2023

International journal of molecular sciences

D'Agostino A, Lanzafame LG, Buono L, Crisci G, D'Assante R +5 more

Plain English
This study looked at how the nitric oxide pathway affects pulmonary arterial hypertension (PAH), a serious condition that causes high blood pressure in the lungs. Researchers found that existing treatments, like sildenafil, tadalafil, and riociguat, can help improve patients' ability to exercise and their blood flow in the lungs. Understanding this pathway is crucial because it can inform better treatments and improve patient outcomes in PAH, a condition that has limited effective therapies. Who this helps: This information helps patients with pulmonary arterial hypertension and their doctors.

PubMed

Elderberry Lipophilic and Hydrophilic Bioactive Compounds: Characterization and Extract Encapsulation.

2023

Foods (Basel, Switzerland)

Domínguez-Valencia R, Cittadini A, Pateiro M, Munekata PES, Lorenzo JM

Plain English
This study focused on elderberry and how to extract and stabilize its beneficial compounds for use in food. Researchers found that the elderberry extract is rich in antioxidants, including anthocyanins and flavonols, and the dry residue from this extraction contained healthy fats and vitamin E. This matters because it helps us better utilize elderberries, promoting sustainability while potentially enhancing the nutritional value of food products. Who this helps: This benefits food manufacturers and consumers looking for healthier options.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.